An orally available small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth in vitro and in vivo
Yajing Xing, Weikai Guo, Min Wu, Jiuqing Xie, Dongxia Huang, Pan Hu, Miaoran Zhou, Lin Zhang, Qiansen Zhang, Peili Wang, Xin Wang, Guixue Wang, Huangan Wu, Cili Zhou, Yihua Chen, Mingyao Liu, Zhengfang Yi, Zhenliang Sun
Topics & Concepts
BCL6Cancer researchLymphomaVenetoclaxGerminal centerIn vivoDruggabilityDiffuse large B-cell lymphomaBiologyChemistryTranscription factorCell growthB cellGeneImmunologyLeukemiaBiochemistryGeneticsAntibodyChronic lymphocytic leukemiaCAR-T cell therapy researchLymphoma Diagnosis and TreatmentProtein Degradation and Inhibitors